A carregar...
Immunosuppressive therapy with rituximab in common variable immunodeficiency
Common variable immunodeficiency (CVID) is the most frequent symptomatic primary antibody deficiency in adulthood and is characterized by the marked reduction of IgG and IgA serum levels. Thanks to the successful use of polyvalent immunoglobulin replacement therapy to treat and prevent recurrent inf...
Na minha lista:
| Publicado no: | Clin Mol Allergy |
|---|---|
| Main Authors: | , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BioMed Central
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6501382/ https://ncbi.nlm.nih.gov/pubmed/31080365 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12948-019-0113-3 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|